AstraZeneca has voluntarily withdrawn its marketing authorisation application with the EU's medicines regulator for its ...

AstraZeneca (AZN) and Daiichi Sankyo (DSNKY) withdraw EU marketing application for lung cancer therapy Dato-DXd. Read more ...

Novo Nordisk resumed its rally on Tuesday, rising to the top of the Stoxx 600 during early deals and adding 5.7% by 11:05 a.m ...

The European MCL Network Phase 3 TRIANGLE study, evaluated ibrutinib in combination with induction immunochemotherapy, both with and without an autologous stem cell transplant, followed by 24 months f ...

European stocks edged higher in cautious trade on Tuesday ahead of Christmas break. The German DAX is not trading today while the ...

The European Medicines Agency has revealed a list of five cities that are preferred as its new location by staff after Brexit, following warnings of a public health disaster if EU leaders pick the ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 502.93% and ...

BENGALURU: Biocon Biologics, a biosimilars company and subsidiary of Biocon, has announced that the European Medicines Agency ...

The FDA is alerting veterinarians about reports of health problems in dogs, including hundreds of deaths, tied to a drug for ...

AstraZeneca said it and Daiichi Sankyo decided to voluntarily withdraw the marketing authorization application in the European Union for advanced lung-cancer treatment Dato-DXd. This decision followed ...

Most European bourses were ahead midday Tuesday, though trading activities were muted as global markets are set to remain closed on Wednesday for the holiday. In corporate news, AstraZeneca (AZN) and ...